Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 144 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed     Text format    


    June 2018
  2. FAHEY JK, Ihdayhid AR, White AJ
    A 42-year-old woman with acute myocardial infarction.
    Heart. 2018 Jun 28. pii: heartjnl-2017-312779. doi: 10.1136/heartjnl-2017-312779
    PubMed     Text format    


    May 2018
  3. DOCHERTY KF, Jhund PS
    Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?
    Heart. 2018 May 14. pii: heartjnl-2018-313371. doi: 10.1136/heartjnl-2018-313371
    PubMed     Text format    


  4. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
    Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
    PubMed     Text format     Abstract available


    April 2018
  5. BEYGUI F, Van Belle E, Ecollan P, Machecourt J, et al
    Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
    Heart. 2018 Apr 25. pii: heartjnl-2018-312950. doi: 10.1136/heartjnl-2018-312950
    PubMed     Text format     Abstract available


  6. NIJJER SS
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967
    PubMed     Text format    


  7. MUNDAL LJ, Igland J, Veierod MB, Holven KB, et al
    Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312706. doi: 10.1136/heartjnl-2017-312706.
    PubMed     Text format     Abstract available


  8. OTTO CM
    Heartbeat: Acute myocardial infarction: one test to diagnose them all?
    Heart. 2018;104:625-627.
    PubMed     Text format    


    March 2018
  9. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    PubMed     Text format     Abstract available


  10. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084
    PubMed     Text format    


  11. SEPEHRVAND N, James SK, Stub D, Khoshnood A, et al
    Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials.
    Heart. 2018 Mar 29. pii: heartjnl-2018-313089. doi: 10.1136/heartjnl-2018-313089
    PubMed     Text format     Abstract available


  12. HAKULINEN C, Pulkki-Raback L, Virtanen M, Jokela M, et al
    Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2018 Mar 27. pii: heartjnl-2017-312663. doi: 10.1136/heartjnl-2017-312663
    PubMed     Text format     Abstract available


  13. EDFORS R, Sahlen A, Szummer K, Renlund H, et al
    Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312436. doi: 10.1136/heartjnl-2017-312436
    PubMed     Text format     Abstract available


  14. GRIMALDI-BENSOUDA L, Danchin N, Dallongeville J, Falissard B, et al
    Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
    Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534
    PubMed     Text format     Abstract available


    February 2018
  15. LAMPREA-MONTEALEGRE JA, McClelland RL, Grams M, Ouyang P, et al
    Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312794. doi: 10.1136/heartjnl-2017-312794
    PubMed     Text format     Abstract available


  16. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Text format     Abstract available


  17. GARD A, Lindahl B, Batra G, Hadziosmanovic N, et al
    Interphysician agreement on subclassification of myocardial infarction.
    Heart. 2018 Feb 16. pii: heartjnl-2017-312409. doi: 10.1136/heartjnl-2017-312409
    PubMed     Text format     Abstract available


  18. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.
    PubMed     Text format    


  19. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Text format     Abstract available


    January 2018
  20. SINGH D, Bhat R, Kothari SS
    25-year-old man with chest pain.
    Heart. 2018;104:72.
    PubMed     Text format     Abstract available


  21. MURPHY A, Johnson CO, Roth GA, Forouzanfar MH, et al
    Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.
    Heart. 2018;104:58-66.
    PubMed     Text format     Abstract available


  22. GREY C, Jackson R, Wells S, Wu B, et al
    First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.
    Heart. 2018;104:51-57.
    PubMed     Text format     Abstract available


    December 2017
  23. STEWART RAH, Colquhoun DM, Marschner SL, Kirby AC, et al
    Persistent psychological distress and mortality in patients with stable coronary artery disease.
    Heart. 2017;103:1860-1866.
    PubMed     Text format     Abstract available


  24. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Text format     Abstract available


  25. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available


  26. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    PubMed     Text format    


  27. SAINSBURY PA, Fisher M, de Silva R
    Alternative interventions for refractory angina.
    Heart. 2017;103:1911-1922.
    PubMed     Text format    


    November 2017
  28. DURKO AP, Budde RPJ, Geleijnse ML, Kappetein AP, et al
    Recognition, assessment and management of the mechanical complications of acute myocardial infarction.
    Heart. 2017 Nov 16. pii: heartjnl-2017-311473. doi: 10.1136/heartjnl-2017-311473
    PubMed     Text format    


  29. MANGION K, Gao H, Husmeier D, Luo X, et al
    Advances in computational modelling for personalised medicine after myocardial infarction.
    Heart. 2017 Nov 10. pii: heartjnl-2017-311449. doi: 10.1136/heartjnl-2017-311449
    PubMed     Text format     Abstract available


  30. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    PubMed     Text format     Abstract available


  31. MATULEVICIENE-ANANGEN V, Rosengren A, Svensson AM, Pivodic A, et al
    Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
    Heart. 2017;103:1687-1695.
    PubMed     Text format     Abstract available


  32. HOORWEG BB, Willemsen RT, Cleef LE, Boogaerts T, et al
    Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses.
    Heart. 2017;103:1727-1732.
    PubMed     Text format     Abstract available


  33. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Text format     Abstract available


  34. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Text format     Abstract available


  35. DENBY KJ, Clark DE, Markham LW
    Management of Kawasaki disease in adults.
    Heart. 2017;103:1760-1769.
    PubMed     Text format     Abstract available


  36. HERRINGTON WG, Bragg F
    Extreme ischaemic heart disease risk in people with type 1 diabetes.
    Heart. 2017;103:1656-1657.
    PubMed     Text format    


  37. RAHIMI K, Otto CM
    Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
    Heart. 2017;103:1653-1655.
    PubMed     Text format    


    October 2017
  38. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880
    PubMed     Text format    


  39. OTTO CM
    Heartbeat: Virtual histopathology after myocardial infarction.
    Heart. 2017;103:1473-1474.
    PubMed     Text format    


  40. OTTO CM
    Heartbeat: Ischemic heart disease risk factors in women.
    Heart. 2017;103:1559-1561.
    PubMed     Text format    


  41. ASHER E, Kogan A, Segev A
    Severe upper abdominal pain in a 43-year-old woman.
    Heart. 2017;103:1650.
    PubMed     Text format     Abstract available


  42. MADONIS SM, Skelding KA, Roberts M
    Management of acute coronary syndromes: special considerations in women.
    Heart. 2017;103:1638-1646.
    PubMed     Text format    


    September 2017
  43. ZHAO M, Vaartjes I, Graham I, Grobbee D, et al
    Sex differences in risk factor management of coronary heart disease across three regions.
    Heart. 2017 Sep 20. pii: heartjnl-2017-311429. doi: 10.1136/heartjnl-2017-311429
    PubMed     Text format     Abstract available


  44. ALBADRI A, Wei J, Mehta PK, Shah R, et al
    Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
    Heart. 2017 Sep 20. pii: heartjnl-2017-311921. doi: 10.1136/heartjnl-2017-311921
    PubMed     Text format    


  45. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    PubMed     Text format     Abstract available


  46. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    PubMed     Text format     Abstract available


  47. WANG M, Vaez M, Dorner TE, Tiihonen J, et al
    Trajectories and characteristics of work disability before and after acute myocardial infarction.
    Heart. 2017 Sep 1. pii: heartjnl-2017-311950. doi: 10.1136/heartjnl-2017-311950.
    PubMed     Text format     Abstract available


    August 2017
  48. BERG J, Bjorck L, Nielsen S, Lappas G, et al
    Sex differences in survival after myocardial infarction in Sweden, 1987-2010.
    Heart. 2017 Aug 7. pii: heartjnl-2016-310281. doi: 10.1136/heartjnl-2016-310281.
    PubMed     Text format     Abstract available


  49. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311695. doi: 10.1136/heartjnl-2017-311695.
    PubMed     Text format    


  50. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    PubMed     Text format     Abstract available


  51. WILSON S, Newby DE
    Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Heart. 2017;103:1143-1145.
    PubMed     Text format    


    July 2017
  52. YILMAZ A
    Visualising inflammation after myocardial infarction with the use of iron oxide nanoparticles.
    Heart. 2017 Jul 20. pii: heartjnl-2017-311484. doi: 10.1136/heartjnl-2017-311484
    PubMed     Text format    


  53. FABRIS E, Kilic S, Schellings DAAM, Ten Berg JM, et al
    Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.
    Heart. 2017 Jul 5. pii: heartjnl-2017-311181. doi: 10.1136/heartjnl-2017-311181.
    PubMed     Text format     Abstract available


  54. TIMMIS A, Roobottom CA
    National Institute for Health and Care Excellence updates the stable chest pain guideline with radical changes to the diagnostic paradigm.
    Heart. 2017;103:982-986.
    PubMed     Text format     Abstract available


  55. GONZALEZ LOPEZ-VALCARCEL B, Librero J, Garcia-Sempere A, Pena LM, et al
    Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.
    Heart. 2017;103:1082-1088.
    PubMed     Text format     Abstract available


  56. ZHOU RH, Yu H, Yin XR, Li Q, et al
    Effect of intralipid postconditioning on myocardial injury in patients undergoing valve replacement surgery: a randomised controlled trial.
    Heart. 2017;103:1122-1127.
    PubMed     Text format     Abstract available


  57. SHIMADA YJ, Tsugawa Y, Iso H, Brown DF, et al
    Association between bariatric surgery and rate of hospitalisations for stable angina pectoris in obese adults.
    Heart. 2017;103:1009-1014.
    PubMed     Text format     Abstract available


  58. HELSEN F, Vandenberk B, De Meester P, Van De Bruaene A, et al
    Appearance of QRS fragmentation late after Mustard/Senning repair is associated with adverse outcome.
    Heart. 2017;103:1036-1042.
    PubMed     Text format     Abstract available


  59. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    PubMed     Text format     Abstract available


  60. OHYA M, Kubo S, Kuwayama A, Miura K, et al
    Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.
    Heart. 2017;103:1002-1008.
    PubMed     Text format     Abstract available


  61. TIMMIS A, Roobottom C
    Re: The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients.
    Heart. 2017;103:1055.
    PubMed     Text format    


  62. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    PubMed     Text format    


  63. OTTO CM, Luiz Ribeiro A
    Heartbeat: Anatomy versus physiology for diagnosis of coronary artery disease.
    Heart. 2017;103:969-971.
    PubMed     Text format    


    June 2017
  64. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2017 Jun 29. pii: heartjnl-2017-311431. doi: 10.1136/heartjnl-2017-311431
    PubMed     Text format     Abstract available


  65. NDREPEPA G
    Psychological distress and mortality in stable coronary heart disease: persistence of high distress means increased risk.
    Heart. 2017 Jun 26. pii: heartjnl-2017-311610. doi: 10.1136/heartjnl-2017-311610
    PubMed     Text format    


  66. STIRRAT CG, Alam SR, MacGillivray TJ, Gray CD, et al
    Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction.
    Heart. 2017 Jun 22. pii: heartjnl-2016-311018. doi: 10.1136/heartjnl-2016-311018
    PubMed     Text format     Abstract available


  67. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed     Text format    


  68. BIELINSKI SJ, Berardi C, Decker PA, Larson NB, et al
    Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310450. doi: 10.1136/heartjnl-2016-310450.
    PubMed     Text format     Abstract available


  69. MOSS AJ, Lim KH, Japp AG
    A 49-year-old with chest pain and collapse.
    Heart. 2017;103:968.
    PubMed     Text format    


    May 2017
  70. RAJANI R, Modi B, Ntalas I, Curzen N, et al
    Non-invasive Fractional Flow Reserve using Computed Tomographic angiography: where are we now and where are we going?
    Heart. 2017 May 30. pii: heartjnl-2016-311029. doi: 10.1136/heartjnl-2016-311029
    PubMed     Text format    


  71. LUIZ RIBEIRO A, Satoshi N, Catherine MO
    Heartbeat: Coronary heart disease, obesity, smoking and long-lasting psychological distress.
    Heart. 2017;103:644.
    PubMed     Text format    


  72. LI X, Yu C, Guo Y, Bian Z, et al
    Tea consumption and risk of ischaemic heart disease.
    Heart. 2017;103:783-789.
    PubMed     Text format     Abstract available


  73. PERERA D, Uppal R, Hogan J
    A 72-year-old male with recurrent syncope.
    Heart. 2017;103:800.
    PubMed     Text format     Abstract available


    April 2017
  74. PRIOR DL, Stevens SR, Holly TA, Krejca M, et al
    Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310693. doi: 10.1136/heartjnl-2016-310693
    PubMed     Text format     Abstract available


  75. CADEMARTIRI F, Nistri S, Tarantini G, Maffei E, et al
    Management of coronary artery disease with cardiac CT beyond gatekeeping.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310473. doi: 10.1136/heartjnl-2016-310473
    PubMed     Text format    


  76. HOLTE E, Kleveland O, Ueland T, Kunszt G, et al
    Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Heart. 2017 Apr 21. pii: heartjnl-2016-310875. doi: 10.1136/heartjnl-2016-310875
    PubMed     Text format     Abstract available


  77. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    


  78. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    PubMed     Text format     Abstract available


  79. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available


  80. THOMPSON LE, Daugherty SL
    Gender disparities in cardiovascular disease prevention.
    Heart. 2017;103:479-480.
    PubMed     Text format    


  81. DE SILVA K, Myat A, Cotton J, James S, et al
    Bleeding associated with the management of acute coronary syndromes.
    Heart. 2017;103:546-562.
    PubMed     Text format    


    March 2017
  82. SEKIGUCHI H, Shimamoto K, Takano M, Kimura M, et al
    Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Heart. 2017 Mar 11. pii: heartjnl-2016-310272. doi: 10.1136/heartjnl-2016-310272
    PubMed     Text format     Abstract available


  83. ANDERSSON DP, Trolle Lagerros Y, Grotta A, Bellocco R, et al
    Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.
    Heart. 2017 Mar 9. pii: heartjnl-2016-310746. doi: 10.1136/heartjnl-2016-310746.
    PubMed     Text format     Abstract available


  84. KUBLER P, Reczuch K
    Optimal stent treatment of cardiogenic shock complicating acute myocardial infarction: bare-metal or drug-eluting stent?
    Heart. 2017 Mar 3. pii: heartjnl-2016-311146. doi: 10.1136/heartjnl-2016-311146.
    PubMed     Text format    


  85. WARD-CAVINESS CK, Xu T, Aspelund T, Thorand B, et al
    Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310789. doi: 10.1136/heartjnl-2016-310789.
    PubMed     Text format     Abstract available


  86. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available


  87. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    PubMed     Text format     Abstract available


    February 2017
  88. WILLIAMS MC, Hunter A, Shah A, Assi V, et al
    Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial.
    Heart. 2017 Feb 28. pii: heartjnl-2016-310129. doi: 10.1136/heartjnl-2016-310129
    PubMed     Text format     Abstract available


  89. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Text format     Abstract available


    January 2017
  90. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Text format     Abstract available


  91. BUENO H, Pocock S, Danchin N, Annemans L, et al
    International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
    Heart. 2017;103:132-138.
    PubMed     Text format     Abstract available


  92. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Text format     Abstract available


  93. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    PubMed     Text format    


  94. GIAVARINI A, Kilic ID, Redondo Dieguez A, Longo G, et al
    Intracoronary Imaging.
    Heart. 2017 Jan 5. pii: heartjnl-2015-307888. doi: 10.1136/heartjnl-2015-307888.
    PubMed     Text format    


  95. CHAPMAN AR, Adamson PD, Mills NL
    Assessment and classification of patients with myocardial injury and infarction in clinical practice.
    Heart. 2017;103:10-18.
    PubMed     Text format     Abstract available


    December 2016
  96. WILLIAMS RB
    Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications.
    Heart. 2016;102:2016.
    PubMed     Text format    


  97. REINDL M, Reinstadler SJ, Feistritzer HJ, Mueller L, et al
    Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
    Heart. 2016 Dec 15. pii: heartjnl-2016-310520. doi: 10.1136/heartjnl-2016-310520
    PubMed     Text format     Abstract available


  98. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    PubMed     Text format    


  99. JENKINS WS, Vesey AT, Stirrat C, Connell M, et al
    Cardiac alphaVbeta3 integrin expression following acute myocardial infarction in humans.
    Heart. 2016 Dec 7. pii: heartjnl-2016-310115. doi: 10.1136/heartjnl-2016-310115.
    PubMed     Text format     Abstract available


    November 2016
  100. LLOYD A, Steele L, Fotheringham J, Iqbal J, et al
    Pronounced increase in risk of acute ST-segment elevation myocardial infarction in younger smokers.
    Heart. 2016 Nov 29. pii: heartjnl-2016-309595. doi: 10.1136/heartjnl-2016-309595
    PubMed     Text format     Abstract available


  101. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
    PubMed     Text format    


  102. VIRTANEN M, Elovainio M, Josefsson K, Batty GD, et al
    Coronary heart disease and risk factors as predictors of trajectories of psychological distress from midlife to old age.
    Heart. 2016 Nov 18. pii: heartjnl-2016-310207. doi: 10.1136/heartjnl-2016-310207
    PubMed     Text format     Abstract available


  103. MCMULLAN CJ, Rimm EB, Schernhammer ES, Forman JP, et al
    A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
    Heart. 2016 Nov 2. pii: heartjnl-2016-310098. doi: 10.1136/heartjnl-2016-310098.
    PubMed     Text format     Abstract available


  104. CHAPMAN AR, Anand A, Shah AS, Adamson PD, et al
    Response: a novel troponin I rule-out value below the upper reference limit for acute myocardial infarction.
    Heart. 2016;102:1772.
    PubMed     Text format    


    October 2016
  105. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Text format     Abstract available


    September 2016
  106. GURUNATHAN S, Ahmed A, Pabla J, Karogiannis N, et al
    The clinical efficacy and long-term prognostic value of stress echocardiography in octogenarians.
    Heart. 2016 Sep 30. pii: heartjnl-2016-310026. doi: 10.1136/heartjnl-2016-310026
    PubMed     Text format     Abstract available


  107. MACINTYRE CR, Mahimbo A, Moa AM, Barnes M, et al
    Influenza vaccine as a coronary intervention for prevention of myocardial infarction.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309983. doi: 10.1136/heartjnl-2016-309983
    PubMed     Text format     Abstract available


  108. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Text format     Abstract available


  109. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
    PubMed     Text format     Abstract available


  110. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  111. COCKBURN J, Hildick-Smith D, Trivedi U, de Belder A, et al
    Coronary revascularisation in the elderly.
    Heart. 2016 Sep 14. pii: heartjnl-2015-308999. doi: 10.1136/heartjnl-2015-308999
    PubMed     Text format    


    August 2016
  112. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.
    PubMed     Text format    


  113. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.
    PubMed     Text format    


  114. BRADLEY SM, Otto CM
    Heartbeat: Rule-out of acute myocardial infarction - risky business.
    Heart. 2016;102:1249-50.
    PubMed     Text format    


  115. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    PubMed     Text format     Abstract available


  116. LINDAHL B, Jernberg T, Badertscher P, Boeddinghaus J, et al
    An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay.
    Heart. 2016 Aug 2. pii: heartjnl-2016-309951. doi: 10.1136/heartjnl-2016-309951.
    PubMed     Text format     Abstract available


  117. OTTO CM
    Heartbeat: Prediction of coronary disease risk with cardiac troponin in the general population.
    Heart. 2016;102:1151-2.
    PubMed     Text format    


    July 2016
  118. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    PubMed     Text format     Abstract available


  119. DEVI R, Singh SJ, Powell J, Fulton EA, et al
    Cochrane Corner: are there benefits of using web-based interventions in the secondary prevention of coronary heart disease?
    Heart. 2016 Jul 21. pii: heartjnl-2015-309138. doi: 10.1136/heartjnl-2015-309138
    PubMed     Text format    


  120. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    PubMed     Text format     Abstract available


  121. MITTAL TK, Reichmuth L, Ariff B, Rao PP, et al
    Imaging diagnoses and outcome in patients presenting for primary angioplasty but no obstructive coronary artery disease.
    Heart. 2016 Jul 1. pii: heartjnl-2015-309039. doi: 10.1136/heartjnl-2015-309039.
    PubMed     Text format     Abstract available


    June 2016
  122. PARSONAGE WA, Mueller C, Greenslade JH, Wildi K, et al
    Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309270. doi: 10.1136/heartjnl-2016-309270
    PubMed     Text format     Abstract available


    May 2016
  123. PUDDU PE, Alexandre J
    Coronary heart disease and sexual activity.
    Heart. 2016 May 12. pii: heartjnl-2016-309505. doi: 10.1136/heartjnl-2016-309505
    PubMed     Text format    


  124. NORDMANN A, Schwartz G, Vale N, Bucher HC, et al
    Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
    Heart. 2016;102:653-4.
    PubMed     Text format    


    April 2016
  125. HEMKENS LG, Ewald H, Gloy VL, Arpagaus A, et al
    Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
    Heart. 2016;102:590-6.
    PubMed     Text format     Abstract available


  126. SHAVELLE DM
    Almanac 2015: coronary artery disease.
    Heart. 2016;102:492-9.
    PubMed     Text format     Abstract available


    March 2016
  127. BRICENO N, Schuster A, Lumley M, Perera D, et al
    Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.
    Heart. 2016;102:397-406.
    PubMed     Text format    


  128. BULLUCK H, Yellon DM, Hausenloy DJ
    Reducing myocardial infarct size: challenges and future opportunities.
    Heart. 2016;102:341-8.
    PubMed     Text format     Abstract available


  129. GAIBAZZI N
    Ultrasound contrast during stress echo: for obese patients, but not only.
    Heart. 2016;102:339-40.
    PubMed     Text format    


  130. TARKIA M, Stark C, Haavisto M, Kentala R, et al
    Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Heart. 2016;102:465-71.
    PubMed     Text format     Abstract available


  131. BUDOFF MJ
    Exercise capacity and biological age.
    Heart. 2016;102:415.
    PubMed     Text format    


  132. BLAHA MJ, Hung RK, Dardari Z, Feldman DI, et al
    Age-dependent prognostic value of exercise capacity and derivation of fitness-associated biologic age.
    Heart. 2016;102:431-7.
    PubMed     Text format     Abstract available


  133. ARRI SS, Ryan M, Redwood SR, Marber MS, et al
    Mental stress-induced myocardial ischaemia.
    Heart. 2016;102:472-80.
    PubMed     Text format    


  134. MISTRY A, McCann G, Skehan D
    Ischaemic chest pain in a 65-year-old man.
    Heart. 2016;102:471.
    PubMed     Text format    


    February 2016
  135. VELDERS MA, Abtan J, Angiolillo DJ, Ardissino D, et al
    Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
    Heart. 2016 Feb 4. pii: heartjnl-2015-308963. doi: 10.1136/heartjnl-2015-308963.
    PubMed     Text format     Abstract available


    January 2016
  136. FORDYCE CB, Douglas PS
    Optimal non-invasive imaging test selection for the diagnosis of ischaemic heart disease.
    Heart. 2016 Jan 29. pii: heartjnl-2015-307764. doi: 10.1136/heartjnl-2015-307764
    PubMed     Text format    


  137. AGUS AM, McKavanagh P, Lusk L, Verghis RM, et al
    The cost-effectiveness of cardiac computed tomography for patients with stable chest pain.
    Heart. 2016 Jan 14. pii: heartjnl-2015-308247. doi: 10.1136/heartjnl-2015-308247
    PubMed     Text format     Abstract available


  138. SHAH BN, Zacharias K, Pabla JS, Karogiannis N, et al
    The clinical impact of contemporary stress echocardiography in morbid obesity for the assessment of coronary artery disease.
    Heart. 2016 Jan 6. pii: heartjnl-2015-308796. doi: 10.1136/heartjnl-2015-308796.
    PubMed     Text format     Abstract available


  139. SINCLAIR H, Kunadian V
    Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes.
    Heart. 2016 Jan 6. pii: heartjnl-2015-307859. doi: 10.1136/heartjnl-2015-307859.
    PubMed     Text format     Abstract available


  140. CULLEN L, Greenslade JH, Carlton EW, Than M, et al
    Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.
    Heart. 2016;102:120-6.
    PubMed     Text format     Abstract available


  141. GIANNITSIS E
    Sex-specific troponin measures for diagnosis of acute coronary syndrome.
    Heart. 2016;102:91-2.
    PubMed     Text format    


  142. TASEVSKA I, Enhorning S, Persson M, Nilsson PM, et al
    Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Heart. 2016;102:127-32.
    PubMed     Text format     Abstract available


    December 2015
  143. DASTIDAR AG, Rodrigues JC, Baritussio A, Bucciarelli-Ducci C, et al
    MRI in the assessment of ischaemic heart disease.
    Heart. 2015 Dec 30. pii: heartjnl-2014-306963. doi: 10.1136/heartjnl-2014-306963
    PubMed     Text format    


  144. SINTEK MA, Sparrow CT, Mikuls TR, Lindley KJ, et al
    Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308634. doi: 10.1136/heartjnl-2015-308634
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: